Turkey is a key destination for breast cancer treatment, with top clinics like Anadolu Medical Center, Memorial Şişli Hospital, and Lokman Hekim Istanbul Hospital. These institutions are accredited by the Joint Commission International (JCI), ensuring high standards of care. Anadolu Medical Center, affiliated with Johns Hopkins Medicine, specializes in targeted therapy, immunotherapy, and robotic surgery. Memorial Şişli Hospital, Turkey's first JCI-accredited hospital, boasts advanced cancer care and a 90% transplant success rate. Lokman Hekim Istanbul Hospital, certified by TÜV NORD CERT, offers minimally invasive surgeries and advanced radiotherapy.
The breast cancer survival rate in Turkey reaches approximately 86%, comparable to Western countries. Innovative procedures include oncoplastic surgery, cryoablation, intraoperative radiotherapy (IORT), and proton therapy, attracting international patients seeking effective treatment. Turkey's combination of affordability, advanced technology, and skilled medical professionals makes it a preferred destination for breast cancer care.